The Role of MicroRNAs in Myocardial Infarction: From Molecular Mechanism to Clinical Application

Int J Mol Sci. 2017 Mar 31;18(4):745. doi: 10.3390/ijms18040745.

Abstract

MicroRNAs (miRNAs) are a class of small single-stranded and highly conserved non-coding RNAs, which are closely linked to cardiac disorders such as myocardial infarction (MI), cardiomyocyte hypertrophy, and heart failure. A growing number of studies have demonstrated that miRNAs determine the fate of the heart by regulating cardiac cell death and regeneration after MI. A deep understanding of the pathophysiology of miRNA dependent regulatory pathways in these processes is required. The role of miRNAs as diagnostic, prognostic, and therapeutic targets also needs to be explored in order to utilize them in clinical settings. This review summarizes the role of miRNAs in myocardial infarction and focuses mainly on their influence on cardiomyocyte regeneration and cell death including apoptosis, necrosis, and autophagy. In addition, the targets of pro- and anti-MI miRNAs are comparatively described. In particular, the possibilities of miRNA-based diagnostic and therapeutic strategies for myocardial infarction are discussed in this review.

Keywords: cardiomyocyte regeneration; clinical application; microRNAs; myocardial cell death; myocardial infarction.

Publication types

  • Review

MeSH terms

  • Animals
  • Gene Expression Regulation*
  • Heart Failure / diagnosis
  • Heart Failure / genetics*
  • Heart Failure / therapy
  • Humans
  • MicroRNAs / genetics*
  • Models, Cardiovascular
  • Models, Genetic
  • Myocardial Infarction / diagnosis
  • Myocardial Infarction / genetics*
  • Myocardial Infarction / therapy
  • Myocytes, Cardiac / metabolism*
  • Myocytes, Cardiac / pathology
  • Translational Research, Biomedical / methods
  • Translational Research, Biomedical / trends

Substances

  • MicroRNAs